DiagnoBac's - About the company
DiagnoBac's is an unfunded company based in India, founded in 2025. It operates as a Developer of biosensors for the detection of various target analytes. DiagnoBac's has not raised any funding yet. The company has 98 active competitors, including 18 funded and 7 that have exited. Its top competitors include companies like Monod, Hememics Biotechnologies and ArgusEye.
Company Details
Developer of biosensors for the detection of various target analytes. Technology utilizes engineered biology and artificial intelligence to identify substances for monitoring safety and quality standards. Systems are designed for deployment in industries to facilitate testing and analysis.
- Website
- diagnobacs.com
- Registered Address
- 41/130-1-1, BHARATHI, BAR STREET, Shankarapuram (Cuddapah), Cuddapah, Cuddapah, Andhra Pradesh, India, 516002
Key Metrics
Legal entities associated with DiagnoBac's
DiagnoBac's is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
DIAGNOBAC'S PRIVATE LIMITED CIN: U72100AP2025PTC119063 , India, Active | Apr 25, 2025 | - | - |
Sign up to download DiagnoBac's' company profile
DiagnoBac's's funding and investors
DiagnoBac's has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
DiagnoBac's's Competitors and alternates
Top competitors of DiagnoBac's include Monod, Hememics Biotechnologies and ArgusEye. Here is the list of Top 10 competitors of DiagnoBac's, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Monod 2021, Seattle (United States), Seed | Developer of biosensors to detect viral proteins, toxins, antibodies, and other molecules | $25M | 54/100 | |
2nd |  Hememics Biotechnologies 2009, Gaithersburg (United States), Seed | Developer of techology platform for biopreservation | $4.6M | 50/100 | |
3rd | Provider of biosensor solutions for real time detection of biological systems and processes | $3.02M | 49/100 | ||
4th | Cardea Bio 2019, San Diego (United States), Acquired | Developer of digital graphene biosensors using ML | $21.8M | 44/100 | |
5th |  The Wave Talk 2016, Seoul (South Korea), Seed | Developer of biosensors to detect and monitor micro-organisms | $2M | 43/100 | |
6th |  Aligned Bio 2019, Lund (Sweden), Seed | Provider of nanowire-based sensors | $909K | 42/100 | |
7th | CyanoGuard 2016, Wadenswil (Switzerland), Seed | Developer of the next-generation cyanide monitoring device | $3.77M | 40/100 | |
8th |  Assay Quant 2015, Marlborough (United States), Series A | Provider of SOX technology sensors for detection of protein kinase activity | $4.5M | 37/100 | |
9th | Annaida 2018, Lausanne (Switzerland), Seed | Developer of sensor using magnetic resonance | $1.06M | 35/100 | |
10th | Nanomed 2001, San Diego (United States), Series B | Developer of the device for the small molecules and proteins screening | $11.7M | 35/100 | |
115th |  DiagnoBac's 2025, India, Unfunded | Developer of biosensors for the detection of various target analytes | - | - | - |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on DiagnoBac's's competitors? Click here to see the top ones
DiagnoBac's's Investments and acquisitions
DiagnoBac's has made no investments or acquisitions yet.
Reports related to DiagnoBac's
Here is the latest report on DiagnoBac's's sector:
Are you a Founder ?
FAQs about DiagnoBac's
Explore our recently published companies
- Home Catalyst - Minneapolis based, 2023 founded, Seed company
- Avro - Unfunded company
- Noahlogy - Seed company
- Xitox - United Kingdom based, Unfunded company
- San Antonio Local Press - San Antonio based, Unfunded company
- Daily Bulletin Wire - Unfunded company
